Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


01.01.2018

1 AJR Am J Roentgenol
4 Am J Gastroenterol
4 Am J Pathol
2 Anticancer Res
8 Biochem Biophys Res Commun
6 BMC Cancer
3 BMC Gastroenterol
1 Cancer
1 Cancer Res
2 Dig Dis Sci
2 Gastroenterology
3 Gut
18 Hepatology
1 Int J Cancer
1 J Comput Assist Tomogr
3 J Gastroenterol Hepatol
3 J Hepatol
1 Lancet Gastroenterol Hepatol
6 PLoS One
1 Radiology
6 Semin Liver Dis
3 Transplant Proc
3 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. CUI J, Smolinski SE, Liu F, Xu D, et al
    Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    AJR Am J Roentgenol. 2017 Dec 20:1-9. doi: 10.2214/AJR.17.18222.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. BASILI S, Raparelli V, Napoleone L, Talerico G, et al
    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017457. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available

  3. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available

  4. BARATTA F, Pastori D, Polimeni L, Bucci T, et al
    Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Am J Gastroenterol. 2017;112:1832-1839.
    PubMed     Text format     Abstract available

  5. LIU K, Wong VW, Lau K, Liu SD, et al
    Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.
    Am J Gastroenterol. 2017;112:1812-1823.
    PubMed     Text format     Abstract available


    Am J Pathol

  6. SULAS P, Di Tommaso L, Novello C, Rizzo F, et al
    A large set of miRNAs is dysregulated since the earliest steps of human hepatocellular carcinoma development.
    Am J Pathol. 2017 Dec 14. pii: S0002-9440(17)30783.
    PubMed     Text format     Abstract available

  7. CARPINO G, Cardinale V, Folseraas T, Overi D, et al
    Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis.
    Am J Pathol. 2017 Dec 14. pii: S0002-9440(17)30740.
    PubMed     Text format     Abstract available

  8. KENNEDY L, Hargrove L, Demieville J, Bailey J, et al
    Knockout of l-Histidine Decarboxylase (HDC(-/-)) Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.
    Am J Pathol. 2017 Dec 14. pii: S0002-9440(17)30615.
    PubMed     Text format     Abstract available

  9. LI L, Qian M, Chen IH, Finkelstein D, et al
    Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.
    Am J Pathol. 2017 Dec 14. pii: S0002-9440(17)30865.
    PubMed     Text format     Abstract available


    Anticancer Res

  10. KURAMOTO K, Beppu T, Nitta H, Imai K, et al
    Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Anticancer Res. 2018;38:525-531.
    PubMed     Text format     Abstract available

  11. YOSHIMOTO T, Imura S, Morine Y, Ikemoto T, et al
    The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
    Anticancer Res. 2018;38:501-507.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  12. WU L, Qiu W, Sun J, Wang J, et al
    SENP1 attenuates the liver fibrosis through down-regulating the expression of SMAD2.
    Biochem Biophys Res Commun. 2018;495:755-760.
    PubMed     Text format     Abstract available

  13. ZHOU F, Bai M, Zhang Y, Zhu Q, et al
    Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77.
    Biochem Biophys Res Commun. 2017 Dec 13. pii: S0006-291X(17)32464.
    PubMed     Text format     Abstract available

  14. GENG S, Zhu W, Wang S, Xie C, et al
    P53 modulates hepatic insulin sensitivity through NF-kappaB and p38/ERK MAPK pathways.
    Biochem Biophys Res Commun. 2017 Dec 16. pii: S0006-291X(17)32479.
    PubMed     Text format     Abstract available

  15. TANAKA T, Ohashi S, Saito H, Wada T, et al
    Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2017 Dec 21. pii: S0006-291X(17)32506.
    PubMed     Text format     Abstract available

  16. BARNAULT R, Lahlali T, Plissonnier ML, Romero-Lopez C, et al
    Hepatocellular carcinoma-associated depletion of the netrin-1 receptor Uncoordinated Phenotype-5A (UNC5A) skews the hepatic unfolded protein response towards prosurvival outcomes.
    Biochem Biophys Res Commun. 2017 Dec 22. pii: S0006-291X(17)32529.
    PubMed     Text format     Abstract available

  17. NGUYEN G, Park SY, Le CT, Park WS, et al
    Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Biochem Biophys Res Commun. 2017 Dec 23. pii: S0006-291X(17)32543.
    PubMed     Text format     Abstract available

  18. PARK S, Kim S, Kim MJ, Hong Y, et al
    GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver.
    Biochem Biophys Res Commun. 2018;495:594-600.
    PubMed     Text format     Abstract available

  19. LIU Y, Lu Z, Shi Y, Sun F, et al
    AMOT is required for YAP function in high glucose induced liver malignancy.
    Biochem Biophys Res Commun. 2018;495:1555-1561.
    PubMed     Text format     Abstract available


    BMC Cancer

  20. KIM HA, Kim KA, Choi JI, Lee JM, et al
    Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    BMC Cancer. 2017;17:877.
    PubMed     Text format     Abstract available

  21. SARTORIUS K, Sartorius B, Kramvis A, Singh E, et al
    Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
    BMC Cancer. 2017;17:894.
    PubMed     Text format     Abstract available

  22. KAEMMERER D, Schindler R, Mussbach F, Dahmen U, et al
    Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
    BMC Cancer. 2017;17:896.
    PubMed     Text format     Abstract available

  23. ZHANG XP, Wang K, Li N, Zhong CQ, et al
    Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    BMC Cancer. 2017;17:902.
    PubMed     Text format     Abstract available

  24. TAJUL ARIFIN K, Sulaiman S, Md Saad S, Ahmad Damanhuri H, et al
    Elevation of tumour markers TGF-beta, M2-PK, OV-6 and AFP in hepatocellular carcinoma (HCC)-induced rats and their suppression by microalgae Chlorella vulgaris.
    BMC Cancer. 2017;17:879.
    PubMed     Text format     Abstract available

  25. HAYASHI T, Yamashita T, Terashima T, Suda T, et al
    Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
    BMC Cancer. 2017;17:870.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  26. JI Q, Chu ZQ, Ren T, Xu SC, et al
    Multiparametric functional magnetic resonance imaging for evaluation of hepatic warm ischemia-reperfusion injury in a rabbit model.
    BMC Gastroenterol. 2017;17:161.
    PubMed     Text format     Abstract available

  27. ACHILLI P, Guttadauro A, Bonfanti P, Terragni S, et al
    Streptococcus agalactiae infective endocarditis complicated by multiple mycotic hepatic aneurysms and massive splenic infarction: a case report.
    BMC Gastroenterol. 2017;17:170.
    PubMed     Text format     Abstract available

  28. LEI JW, Ji XY, Hong JF, Li WB, et al
    Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma.
    BMC Gastroenterol. 2017;17:171.
    PubMed     Text format     Abstract available


    Cancer

  29. NEUWIRTH MG, Bierema C, Sinnamon AJ, Fraker DL, et al
    Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?
    Cancer. 2018;124:125-135.
    PubMed     Text format     Abstract available


    Cancer Res

  30. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  31. JONES PD, Diaz C, Wang D, Gonzalez-Diaz J, et al
    The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4869.
    PubMed     Text format     Abstract available

  32. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    PubMed     Text format     Abstract available


    Gastroenterology

  33. WU X, Dao Thi VL, Liu P, Takacs CN, et al
    Pan-Genotype Hepatitis E Virus Replication in Stem Cell-derived Hepatocellular Systems.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36303.
    PubMed     Text format     Abstract available

  34. ZHANG S, Nguyen LH, Zhou K, Tu HC, et al
    Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice without Affecting Regeneration.
    Gastroenterology. 2017 Dec 20. pii: S0016-5085(17)36717.
    PubMed     Text format     Abstract available


    Gut

  35. NEWSOME PN, Cramb R, Davison SM, Dillon JF, et al
    Guidelines on the management of abnormal liver blood tests.
    Gut. 2018;67:6-19.
    PubMed     Text format     Abstract available

  36. WIESER V, Adolph TE, Grander C, Grabherr F, et al
    Adipose type I interferon signalling protects against metabolic dysfunction.
    Gut. 2018;67:157-165.
    PubMed     Text format     Abstract available

  37. DIETRICH P, Koch A, Fritz V, Hartmann A, et al
    Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance.
    Gut. 2017 Dec 23. pii: gutjnl-2017-315402. doi: 10.1136/gutjnl-2017-315402.
    PubMed     Text format     Abstract available


    Hepatology

  38. BRISEBOIS A, Ismond KP, Carbonneau M, Tandon P, et al
    Advance Care Planning (ACP) for specialists managing cirrhosis: a focus on patient-centered care.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29731.
    PubMed     Text format     Abstract available

  39. NOVIKOV A, Schwartz RE, Mukewar S, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2018;67:1-3.
    PubMed     Text format    

  40. CHO CS, Park HW, Ho A, Semple IA, et al
    Lipotoxicity induces hepatic protein inclusions through TBK1-mediated p62/SQSTM1 phosphorylation.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29742.
    PubMed     Text format     Abstract available

  41. ZOU X, Ramachandran P, Kendall TJ, Pellicoro A, et al
    11betaHSD1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29734.
    PubMed     Text format     Abstract available

  42. SHAN Z, Liu X, Chen Y, Wang M, et al
    Chitinase 3-like-1 Promotes Intrahepatic Activation of Coagulation Through Induction of Tissue Factor in Mice.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29733.
    PubMed     Text format     Abstract available

  43. KIM E, Kim D, Lee JS, Yoe J, et al
    Capicua suppresses hepatocellular carcinoma progression by controlling ETV4-MMP1 axis.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29738.
    PubMed     Text format     Abstract available

  44. SU TH, Tseng TC, Kao JH
    HCC risk in patients with HBV-related cirrhosis receiving NA therapy: is HCC prevented or delayed?
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29740.
    PubMed     Text format    

  45. SPELIOTES EK
    Thwart your destiny; effect of NAFLD genes on steatosis, liver injury and cirrhosis varies by body mass index.
    Hepatology. 2017 Dec 18. doi: 10.1002/hep.29739.
    PubMed     Text format    

  46. ZHENG B, Zhu YJ, Jeong S, Wang HY, et al
    Risk stratification ofhepatic encephalopathy in liver cirrhosis patients: Novel strategy with novel concerns.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29747.
    PubMed     Text format    

  47. TAPPER EB, Lok AS, Su GL
    Re: Risk stratification of suffering hepatic encephalopathy in liver cirrhosis patients: novel strategy with novel concerns.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29746.
    PubMed     Text format    

  48. SO J, Khaliq M, Evason K, Ninov N, et al
    Wnt/beta-catenin signaling controls intrahepatic biliary network formation in zebrafish by regulating Notch activity.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29752.
    PubMed     Text format     Abstract available

  49. ZIOL M, Pote N, Amaddeo G, Laurent A, et al
    Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
    Hepatology. 2017 Dec 27. doi: 10.1002/hep.29762.
    PubMed     Text format     Abstract available

  50. VERMA N, Kaur A, Sharma R, Bhalla A, et al
    Outcomes after Multiple courses of Granulocyte-Colony Stimulating Factor and Growth Hormone in Decompensated Cirrhosis: Randomized Trial.
    Hepatology. 2017 Dec 26. doi: 10.1002/hep.29763.
    PubMed     Text format     Abstract available

  51. NEPAL C, O'Rourke CJ, Oliveira DV, Taranta A, et al
    Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma.
    Hepatology. 2017 Dec 26. doi: 10.1002/hep.29764.
    PubMed     Text format     Abstract available

  52. TAPPER EB, Kanwal F, Asrani SK, Ho C, et al
    Patient Reported Outcomes in Cirrhosis: A Scoping Review of the Literature.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29756.
    PubMed     Text format     Abstract available

  53. YOSHIHARA T, Sakamori R, Furuta K, Shigekawa M, et al
    Hepatocellular Carcinoma Due to a Baffle Obstruction After the Mustard Operation: A Case Report.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29758.
    PubMed     Text format     Abstract available

  54. MORELLO E, Sutti S, Foglia B, Novo E, et al
    Hypoxia-inducible factor 2alpha drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein.
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29754.
    PubMed     Text format     Abstract available

  55. KIM DY, Han KH
    Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?
    Hepatology. 2017 Dec 21. doi: 10.1002/hep.29748.
    PubMed     Text format    


    Int J Cancer

  56. CHANG CJ, Yang YH, Chiu CJ, Lu LC, et al
    Targeting tumor-infiltrating Ly6G(+) myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma.
    Int J Cancer. 2017 Dec 20. doi: 10.1002/ijc.31216.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  57. AKAGI M, Nakamura Y, Higaki T, Matsubara Y, et al
    Preliminary Results of High-Precision Computed Diffusion Weighted Imaging for the Diagnosis of Hepatocellular Carcinoma at 3 Tesla.
    J Comput Assist Tomogr. 2017 Dec 28. doi: 10.1097/RCT.0000000000000702.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  58. KAWASHITA Y, Morine Y, Saito Y, Takasu C, et al
    Role of HSF1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
    J Gastroenterol Hepatol. 2017 Dec 26. doi: 10.1111/jgh.14078.
    PubMed     Text format     Abstract available

  59. CRIMI F, Guido M, Pomerri F
    Hepatobiliary and Pancreatic: Hepatic nodules in a patient with familial adenomatous polyposis and colorectal adenocarcinoma.
    J Gastroenterol Hepatol. 2018;33:8.
    PubMed     Text format    

  60. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
    Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
    J Gastroenterol Hepatol. 2018;33:9.
    PubMed     Text format    


    J Hepatol

  61. XU B, Jiang M, Chu Y, Wang W, et al
    Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    J Hepatol. 2017 Dec 19. pii: S0168-8278(17)32494.
    PubMed     Text format     Abstract available

  62. CALDWELL S, Marchesini G
    Cryptogenic vs NASH-cirrhosis: The rose exists well before its name.
    J Hepatol. 2017 Dec 13. pii: S0168-8278(17)32488.
    PubMed     Text format    

  63. LI L, Barry V, Daffis S, Niu C, et al
    Anti-HBV Response to Toll-Like Receptor 7 Agonist GS-9620 is Associated with Intrahepatic Aggregates of T Cells and B Cells.
    J Hepatol. 2017 Dec 14. pii: S0168-8278(17)32490.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol


  64. Correction to Lancet Gastroenterol Hepatol 2017; 2: 877-89.
    Lancet Gastroenterol Hepatol. 2018;3:e1.
    PubMed     Text format    


    PLoS One

  65. ALAZAWI W, Bernabe E, Tai D, Janicki T, et al
    Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0185902.
    PubMed     Text format     Abstract available

  66. BACIU C, Pasini E, Angeli M, Schwenger K, et al
    Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0189223.
    PubMed     Text format     Abstract available

  67. FIGORILLI F, Putignano A, Roux O, Houssel-Debry P, et al
    Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.
    PLoS One. 2017;12:e0188151.
    PubMed     Text format     Abstract available

  68. ROGAL SS, Udawatta V, Akpan I, Moghe A, et al
    Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.
    PLoS One. 2017;12:e0187176.
    PubMed     Text format     Abstract available

  69. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    PubMed     Text format     Abstract available

  70. FEIG JL, Mediero A, Corciulo C, Liu H, et al
    The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.
    PLoS One. 2017;12:e0188135.
    PubMed     Text format     Abstract available


    Radiology

  71. YU SCH, Chan SL, Lee KF, Hui JWY, et al
    Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
    Radiology. 2017 Dec 22:170154. doi: 10.1148/radiol.2017170154.
    PubMed     Text format     Abstract available


    Semin Liver Dis

  72. CAMPANA L, Iredale JP
    Regression of Liver Fibrosis.
    Semin Liver Dis. 2017;37:1-10.
    PubMed     Text format     Abstract available

  73. RICH NE, Parikh ND, Singal AG
    Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance.
    Semin Liver Dis. 2017;37:296-304.
    PubMed     Text format     Abstract available

  74. PARES A
    Novel Treatment Strategies for Primary Biliary Cholangitis.
    Semin Liver Dis. 2017;37:60-72.
    PubMed     Text format     Abstract available

  75. SANTOS-LASO A, Izquierdo-Sanchez L, Lee-Law PY, Perugorria MJ, et al
    New Advances in Polycystic Liver Diseases.
    Semin Liver Dis. 2017;37:45-55.
    PubMed     Text format     Abstract available

  76. TRIPODI A
    Hemostasis in Acute and Chronic Liver Disease.
    Semin Liver Dis. 2017;37:28-32.
    PubMed     Text format     Abstract available

  77. MORALES-RUIZ M, Santel A, Ribera J, Jimenez W, et al
    The Role of Akt in Chronic Liver Disease and Liver Regeneration.
    Semin Liver Dis. 2017;37:11-16.
    PubMed     Text format     Abstract available


    Transplant Proc

  78. CHEDID MF, Bosi HR, Chedid AD, Alvares-da-Silva MR, et al
    One Hundred Consecutive Liver Transplants Using Institutes Georges Lopez-1 Preservation Solution: Outcomes and Prognostic Factors.
    Transplant Proc. 2017;49:848-851.
    PubMed     Text format     Abstract available

  79. ZAOUALI MA, Panisello A, Lopez A, Folch E, et al
    Cross-Talk Between Sirtuin 1 and High-Mobility Box 1 in Steatotic Liver Graft Preservation.
    Transplant Proc. 2017;49:765-769.
    PubMed     Text format     Abstract available

  80. EBOLI L, Tannuri AC, Gibelli N, Silva T, et al
    Comparison of the Results of Living Donor Liver Transplantation Due to Acute Liver Failure and Biliary Atresia in a Quaternary Center.
    Transplant Proc. 2017;49:832-835.
    PubMed     Text format     Abstract available


    Transplantation

  81. SPENGLER EK
    The Author's Reply: Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002064.
    PubMed     Text format    

  82. IANNELLI A, Schiavo L
    Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002065.
    PubMed     Text format    

  83. CHARLTON M, Rinella M, Patel D, McCague K, et al
    Everolimus is Associated With Less Weight Gain Than Tacrolimus 2 Years Following Liver Transplantation: Results of a Randomized Multicenter Study.
    Transplantation. 2017 Aug 15. doi: 10.1097/TP.0000000000001913.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: